The KRAS and NRAS genes, variants of the RAS family, play a crucial role in CRC due to both their mutation frequency and their regulatory influence on pathways controlling cell proliferation, motility, angiogenesis, and survival. This evidence concerns the gene NRAS and colorectal carcinoma.